Published in J Neurooncol on April 01, 1991
Lhermitte Sign as a Presenting Symptom of Thoracic Spinal Pathology: A Case Study. Case Rep Neurol Med (2015) 0.75
Quality-of-life assessment during a palliative care programme. Ann Oncol (1990) 2.67
A validation study of the WHO method for cancer pain relief. Cancer (1987) 2.32
Successful validation of the palliative prognostic score in terminally ill cancer patients. Italian Multicenter Study Group on Palliative Care. J Pain Symptom Manage (1999) 2.30
Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? J Clin Oncol (1998) 2.29
Symptom prevalence and control during cancer patients' last days of life. J Palliat Care (1990) 2.22
Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study. J Clin Oncol (1995) 2.09
Paraplegia following coeliac plexus block. Pain (1993) 1.85
Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain. J Pain Symptom Manage (1999) 1.80
Paclitaxel in metastatic breast cancer: a trial of two doses by a 3-hour infusion in patients with disease recurrence after prior therapy with anthracyclines. J Natl Cancer Inst (1995) 1.63
Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Palliat Med (1993) 1.57
Retrograde cannulation of the jugular vein: erroneous positioning of the catheter in the subarachnoid space. Br J Anaesth (1995) 1.54
Morphine for relief of cancer pain. Lancet (1996) 1.47
Visual disturbances in advanced cancer patients: clinical observations. J Pain Symptom Manage (1999) 1.39
Careful monitoring of the use of sedative drugs at the end of life: the role of Epidemiology. The ITAELD study. Minerva Anestesiol (2014) 1.38
Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group. Br J Cancer (2009) 1.37
Gaucher's disease with Parkinson's disease: clinical and pathological aspects. Neurology (2003) 1.36
Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer (2001) 1.32
Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients. Pain (2011) 1.28
A validation study of an Italian version of the Brief Pain Inventory (Breve Questionario per la Valutazione del Dolore). Pain (1996) 1.22
Impact of delirium on the short term prognosis of advanced cancer patients. Italian Multicenter Study Group on Palliative Care. Cancer (2000) 1.21
WHO guidelines for the use of analgesics in cancer pain. Int J Tissue React (1985) 1.18
Intravenous pamidronate treatment in osteogenesis imperfecta. J Pediatr (1997) 1.17
Peripheral-type benzodiazepine receptor ligands: mitochondrial permeability transition induction in rat cardiac tissue. Biochem Pharmacol (2001) 1.10
Phase-II study of Navelbine in advanced breast cancer. Semin Oncol (1989) 1.09
A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation. Cancer (1998) 1.08
Serum cytokine profiles in acute primary HIV-1 infection and in infectious mononucleosis. Clin Immunol Immunopathol (1996) 1.07
Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21(Cip1) expression and hampers tumour cell growth in vitro and in vivo. Cell Death Differ (2011) 1.06
GABA A/Bz receptor subtypes as targets for selective drugs. Curr Med Chem (2007) 1.06
Characteristics of terminal cancer patients who committed suicide during a home palliative care program. J Pain Symptom Manage (2001) 1.06
2-Arylpyrazolo[1,5-a]pyrimidin-3-yl acetamides. New potent and selective peripheral benzodiazepine receptor ligands. Bioorg Med Chem (2001) 1.05
Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial. J Pain Symptom Manage (2000) 1.04
Mercury in urban soils: a comparison of local spatial variability in six European cities. Sci Total Environ (2006) 1.03
Inhibition of metalloproteinases derived from tumours: new insights in the treatment of human glioblastoma. Neuroscience (2010) 1.02
Bone complications in children with Gaucher disease. Br J Radiol (2002) 1.01
Pain assessment tools in palliative care: an urgent need for consensus. Palliat Med (2008) 1.01
Biological indices predictive of survival in 519 Italian terminally ill cancer patients. Italian Multicenter Study Group on Palliative Care. J Pain Symptom Manage (1997) 1.01
Ultrasound-guided injection of platelet-rich plasma in chronic Achilles and patellar tendinopathy. J Ultrasound (2012) 1.01
Management of bowel obstruction in advanced and terminal cancer patients. Ann Oncol (1993) 1.01
Pain measurement in cancer patients: a comparison of six methods. Pain (1994) 0.99
Assessing delirium in cancer patients: the Italian versions of the Delirium Rating Scale and the Memorial Delirium Assessment Scale. J Pain Symptom Manage (2001) 0.99
Antidepressants increase bioavailability of morphine in cancer patients. Lancet (1987) 0.98
Effect of home care on the place of death of advanced cancer patients. Eur J Cancer (1996) 0.98
1,2,3-Triazolo[1,5-a][1,4]- and 1,2,3-triazolo[1,5-a]-[1,5]benzodiazepine derivatives: synthesis and benzodiazepine receptor binding. Farmaco (1998) 0.96
Synthesis, structure-activity relationships, and molecular modeling studies of N-(indol-3-ylglyoxylyl)benzylamine derivatives acting at the benzodiazepine receptor. J Med Chem (1996) 0.96
Estrogen regulation of adipose tissue functions: involvement of estrogen receptor isoforms. Infect Disord Drug Targets (2008) 0.96
Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia. Prostate (1998) 0.96
Predictors of morbidity and mortality in acromegaly: an Italian survey. Eur J Endocrinol (2012) 0.96
Artificial nutrition and hydration in the last week of life in cancer patients. A systematic literature review of practices and effects. Ann Oncol (2011) 0.96
Agonist-induced desensitization/resensitization of human G protein-coupled receptor 17: a functional cross-talk between purinergic and cysteinyl-leukotriene ligands. J Pharmacol Exp Ther (2011) 0.96
Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial. Eur J Cancer (1998) 0.95
Classification of pain in cancer patients--a systematic literature review. Palliat Med (2009) 0.95
Sodium naproxen versus sodium diclofenac in cancer pain control. Arzneimittelforschung (1990) 0.95
Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine. Pain (1991) 0.95
Surgical treatment of abdominal aortic aneurysm in association with horseshoe kidney. Three case reports and a review of technique. Tex Heart Inst J (1998) 0.95
The management of inoperable gastrointestinal obstruction in terminal cancer patients. Tumori (1990) 0.94
Efficacy of homeopathic treatment of skin reactions during radiotherapy for breast cancer: a randomised, double-blind clinical trial. Br Homeopath J (2000) 0.94
Adenosine receptors: what we know and what we are learning. Curr Top Med Chem (2010) 0.93
Guidelines on artificial nutrition versus hydration in terminal cancer patients. European Association for Palliative Care. Nutrition (1996) 0.92
Ultrasonography of arm edema after axillary dissection for breast cancer: a preliminary study. Lymphology (2001) 0.92
Vinorelbine: an active, non cross-resistant drug in advanced breast cancer. Results from a phase II study. Breast Cancer Res Treat (1996) 0.92
Agonist-induced internalization and recycling of the human A(3) adenosine receptors: role in receptor desensitization and resensitization. J Neurochem (2000) 0.92
Palliative care research. Eur J Cancer (2001) 0.91
A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulation. Mol Pharmacol (2002) 0.91
Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences. Ann Oncol (1998) 0.91
Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction. J Pain Symptom Manage (1991) 0.91
Electrophysiological evaluation of visual pathways in paclitaxel-treated patients. J Neurooncol (2005) 0.90
Suicide among patients with cancer cared for at home by palliative-care teams. Lancet (1999) 0.89
Differences in morbidity patterns among rural, urban, and teaching family practices: a one-year study of twelve Colorado family practices. J Fam Pract (1979) 0.89
Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naïve patients with advanced non-small-cell lung cancer. Ann Oncol (2000) 0.89
A randomized study on oral administration of morphine and methadone in the treatment of cancer pain. J Pain Symptom Manage (1986) 0.89
2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies. J Med Chem (1998) 0.89
Oral complications in patients with advanced cancer. J Palliat Care (1989) 0.89
Comparison of home and hospital care of advanced cancer patients. Tumori (1989) 0.88
Trazodone for deafferentation pain. Comparison with amitriptyline. Psychopharmacology (Berl) (1988) 0.88
Co-localization and functional cross-talk between A1 and P2Y1 purine receptors in rat hippocampus. Eur J Neurosci (2007) 0.88
Propofol in terminal care. J Pain Symptom Manage (1995) 0.87
1,2,4-Triazolo[4,3-a]quinoxalin-1-one: a versatile tool for the synthesis of potent and selective adenosine receptor antagonists. J Med Chem (2000) 0.86
Radiotherapy in stage IIA and IIB testicular seminoma with reduced portals: a prospective multicenter study. Int J Radiat Oncol Biol Phys (1997) 0.86
Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors and outcome. Bone Marrow Transplant (2000) 0.85
Pain experienced by patients hospitalized at the National Cancer Institute of Milan: research project "towards a pain-free hospital". Tumori (2000) 0.85
Evidence for complex binding profiles and species differences at the translocator protein (TSPO) (18 kDa). Curr Mol Med (2012) 0.84
Is target opioid therapy within sight? Minerva Anestesiol (2012) 0.84
Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens. J Clin Endocrinol Metab (2001) 0.84
Importance of a small N-terminal region in mammalian peptide transporters for substrate affinity and function. J Membr Biol (2002) 0.84